R01 CA157881/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2013	1
2014	3
2015	6
2016	6
2017	4
2018	4
2019	3
2020	1
2022	2
2024	0

1

Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus.

Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S; PRACTICAL Consortium; Tammela TLJ, Auvinen A, Wang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH. Gao P, et al. Cell. 2018 Jul 26;174(3):576-589.e18. doi: 10.1016/j.cell.2018.06.003. Epub 2018 Jul 19. Cell. 2018. PMID: 30033361 Free PMC article.

2

Extensive germline-somatic interplay contributes to prostate cancer progression through HNF1B co-option of TMPRSS2-ERG.

Giannareas N, Zhang Q, Yang X, Na R, Tian Y, Yang Y, Ruan X, Huang D, Yang X, Wang C, Zhang P, Manninen A, Wang L, Wei GH. Giannareas N, et al. Nat Commun. 2022 Nov 28;13(1):7320. doi: 10.1038/s41467-022-34994-z. Nat Commun. 2022. PMID: 36443337 Free PMC article.

3

Extracellular microRNAs in urologic malignancies: chances and challenges.

Huang X, Liang M, Dittmar R, Wang L. Huang X, et al. Int J Mol Sci. 2013 Jul 16;14(7):14785-99. doi: 10.3390/ijms140714785. Int J Mol Sci. 2013. PMID: 23863690 Free PMC article. Review.

4

3C-digital PCR for quantification of chromatin interactions.

Du M, Wang L. Du M, et al. BMC Mol Biol. 2016 Dec 6;17(1):23. doi: 10.1186/s12867-016-0076-6. BMC Mol Biol. 2016. PMID: 27923366 Free PMC article.

5

A microRNA Transcriptome-wide Association Study of Prostate Cancer Risk.

Larson NB, McDonnell SK, Fogarty Z, Liu Y, French AJ, Tillmans LS, Cheville JC, Wang L, Schaid DJ, Thibodeau SN. Larson NB, et al. Front Genet. 2022 Mar 30;13:836841. doi: 10.3389/fgene.2022.836841. eCollection 2022. Front Genet. 2022. PMID: 35432445 Free PMC article.

6

Synergistic Interaction of HOXB13 and CIP2A Predisposes to Aggressive Prostate Cancer.

Sipeky C, Gao P, Zhang Q, Wang L, Ettala O, Talala KM, Tammela TLJ, Auvinen A, Wiklund F, Wei GH, Schleutker J. Sipeky C, et al. Clin Cancer Res. 2018 Dec 15;24(24):6265-6276. doi: 10.1158/1078-0432.CCR-18-0444. Epub 2018 Sep 4. Clin Cancer Res. 2018. PMID: 30181389 Free PMC article.

7

miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1.

Wang Y, Lieberman R, Pan J, Zhang Q, Du M, Zhang P, Nevalainen M, Kohli M, Shenoy NK, Meng H, You M, Wang L. Wang Y, et al. Mol Cancer. 2016 Nov 10;15(1):70. doi: 10.1186/s12943-016-0556-9. Mol Cancer. 2016. PMID: 27832783 Free PMC article.

8

Molecular characterization of cell-free eccDNAs in human plasma.

Zhu J, Zhang F, Du M, Zhang P, Fu S, Wang L. Zhu J, et al. Sci Rep. 2017 Sep 8;7(1):10968. doi: 10.1038/s41598-017-11368-w. Sci Rep. 2017. PMID: 28887493 Free PMC article.

9

Plasma genetic and genomic abnormalities predict treatment response and clinical outcome in advanced prostate cancer.

Xia S, Kohli M, Du M, Dittmar RL, Lee A, Nandy D, Yuan T, Guo Y, Wang Y, Tschannen MR, Worthey E, Jacob H, See W, Kilari D, Wang X, Hovey RL, Huang CC, Wang L. Xia S, et al. Oncotarget. 2015 Jun 30;6(18):16411-21. doi: 10.18632/oncotarget.3845. Oncotarget. 2015. PMID: 25915538 Free PMC article.

10

Chromatin interactions and candidate genes at ten prostate cancer risk loci.

Du M, Tillmans L, Gao J, Gao P, Yuan T, Dittmar RL, Song W, Yang Y, Sahr N, Wang T, Wei GH, Thibodeau SN, Wang L. Du M, et al. Sci Rep. 2016 Mar 16;6:23202. doi: 10.1038/srep23202. Sci Rep. 2016. PMID: 26979803 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

26 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year